Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Impact of the IBox As an Early Intervention TooL: a Prospective Randomised Controlled Trial to Assess the Use of a Software Predicting Allograft Survival in the Follow-up of Kidney Transplanted Patients.

NCT05112315 is registered in ClinicalTrials.gov with Predict4Health as lead sponsor.

NCT NCT05112315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05112315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Impact of the IBox As an Early Intervention TooL: a Prospective Randomised Controlled Trial to Assess the Use of a Software Predicting Allograft Survival in the Follow-up of Kidney Transplanted Patients.
Lead sponsor
Predict4Health
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 18, 2022
Completion date
February 28, 2025
Enrollment
507 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

kidney disease, chronic, kidney diseases, kidney dysfunction, kidney failure, kidney failure, chronic, kidney transplant rejection, kidney transplant; complications